In December, Johan Weigelt became CEO of KI Holding. Two months later also CEO at KI Innovations. Being involved in and supporting the development of products that improve people's health and save lives is something he appreciates.

The report by SwedenBIO contains a mapping of the pharmaceutical pipeline run by companies headquartered in Sweden. The target group for the report includes international investors, the life science industry in Sweden and of course decision makers within politics, business and academia. The aim of the report is to be a basis for fact-based improvements of the industry and to promote Sweden’s position in pharmaceutical development. 

Dialog, a long-awaited tool for people with aphasia, and speech therapists, will be launched in April. It provides the possibility for as much speech training as a patient needs, which is difficult today due to a lack of speech therapists.